Randomized, Double-masked, Placebo-controlled Clinical Trial on the Effects of Propolis and Chlorhexidine Mouthrinses on Gingivitis

Authors

  • Camilo Anauate-Netto Biomaterials Research Group – School of Dentistry – UNIBAN Bandeirante Anhanguera University – São Paulo – SP – Brazil.
  • Andréa Anido-Anido School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil
  • Hugo Roberto Lewgoy School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil
  • Ricardo Matsumoto School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil
  • Roberta Caroline Bruschi Alonso School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil
  • Maria Cristina Marcucci School of Pharmacy, UNIBAN Bandeirante Anhanguera University - 02171-013 São Paulo, Brazil
  • Niraldo Paulino School of Pharmacy, UNIBAN Bandeirante Anhanguera University - 02171-013 São Paulo, Brazil
  • Walter Antonio Bretz College of Dentistry, New York University 10010 New York-NY, USA

DOI:

https://doi.org/10.14295/bds.2014.v17i1.947

Abstract

Objective: The aim of this study was to compare the effects of typified propolis and chlorhexidine mouthrinses on gingival health in a randomized double-masked placebo-controlled clinical trial.

Methods: Sixty participants were randomized to 3 mouthrinse study groups: 1) 2% typified propolis (n=20); 2) 0.12% chlorhexidine (n=20), and 3) placebo (n=20). Participants rinsed unsupervised twice a day for 28 days. The Papillary Bleeding Score (PBS) was measured on the mesio-buccal surfaces of all teeth at baseline and 28 days thereafter. Co-variance analysis was employed to compare PBS average values and the number of sites with PBS ?2 among study groups. Sub-group analysis was further applied to participants who were <40 years-old.

Results: The results show efficacy of propolis mouthrinse when comparing before and after treatment protocols significantly for a reduction of mean PBS scores. When looking at younger participants after 28 days, propolis mouthrinse was superior to all groups in reducing mean PBS scores and significantly so when compared to 0.12% chlorhexidine mouthrinse.

Conclusion: The efficacy of 2% typified propolis mouthrinse was demonstrated in reducing the levels of gingival inflammation. These results need to be duplicated by other investigators by employing similar study protocols.

Descriptors: Randomized Clinical Trial, Propolis, Chlorhexidine, Gingivitis

Author Biographies

Andréa Anido-Anido, School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil

Biomaterials Research Group

Hugo Roberto Lewgoy, School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil

Biomaterials Research Group

Ricardo Matsumoto, School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil

Biomaterials Research Group

Roberta Caroline Bruschi Alonso, School of Dentistry, UNIBAN Bandeirante Anhanguera University – 02171-013 São Paulo, Brazil

Biomaterials Research Group

Maria Cristina Marcucci, School of Pharmacy, UNIBAN Bandeirante Anhanguera University - 02171-013 São Paulo, Brazil

Professional Masters Program in Pharmacy

Niraldo Paulino, School of Pharmacy, UNIBAN Bandeirante Anhanguera University - 02171-013 São Paulo, Brazil

Professional Masters Program in Pharmacy

Walter Antonio Bretz, College of Dentistry, New York University 10010 New York-NY, USA

Department of Cariology & Comprehensive Care

Downloads

Published

2014-01-24

Issue

Section

Clinical or Laboratorial Research